Lipid-lowering therapy for coronary heart disease

Hyperlipidemia is seriously jeopardizing human health, this rich disease brings very serious consequences, coronary heart disease, cerebrovascular accidents, systemic atherosclerosis, these diseases have long been occupying the forefront of the common human deaths. Diet is difficult to control, more people turn to drug therapy, especially lipid-lowering drugs are now increasingly used in clinical practice. Statin drugs are now more and more used in the clinic, especially in cardiovascular disease, for the existence of high blood pressure, family coronary heart disease, taking statin drugs is also more and more important. By taking the drugs, not only can lower blood lipids, but also can reduce the risk of coronary heart disease significantly. But do patients who have undergone coronary stenting or coronary bypass surgery need to continue taking the medication? This kind of question is often asked by many patients, in fact, stent surgery or bypass surgery after surgery should take statins, he can effectively maintain the stent or bridge blood vessels of the long-term patency rate, but also to ensure that other blood vessels re-obstruction possible. At the European Cardiovascular Society 2012, the experts suggest that patients and doctors are asked to regain confidence in statins and to improve secondary prevention of coronary heart disease from the healthcare system.